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ABSTRACT 
The overall goal of this Doctor of Nursing Practice (DNP) scholarly project is to 
complete a program evaluation using the Centers of Disease Control (CDC) Framework 
for Program Evaluation to measure the effectiveness of a stroke protocol in a rural 
Nevada hospital. This (DNP) scholarly project evaluates program strategies over third 
and fourth quarters of 2010 as well as the first, second, and third quarters of 2011, that 
have been initiated to reduce the burden of neurological disease with the application of a 
stroke protocol that complies with defined evidence-based strategies for assessment and 
management of stroke victims. As part of a continuous quality-improvement effort, the 
implementation of eight quality-of-care stroke measures have been monitored on a 
quarterly basis both pre and post initiation of the stroke protocol. 
The program evaluation of stroke protocol in a rural Nevada hospital evaluates 
systematic ways to improve procedures that are useful, feasible, ethical, and accurate. 
Application of the Centers of Disease Control (CDC) Framework for Program Evaluation 
answers questions by selecting specific evaluation standards. The logic, reasoning, and 
values of evaluation that are reflected in this framework can lead to lasting impacts, such 
as basing decisions on experimentation instead of unfounded assumptions. The specific 
aim of this program evaluation was to analyze the start of a new program within a rural 
Nevada hospital, to produce information for evaluating the stroke program’s 
effectiveness, and to use this information to make decisions about program refinement, 
revision, and /or continuation. The key to stroke recovery is through early intervention 
and treatment.  
 iv 
 
TABLE OF CONTENTS 
ABSTRACT.......................................................................................................................iii 
CHAPTER I.........................................................................................................................1 
Introduction...................................................................................................................1 
Problem Statement........................................................................................................4 
CHAPTER II.......................................................................................................................7 
Review of the Literature...............................................................................................7 
Needs Assessment and Description............................................................................10 
Mission, Goals, and Objectives Statements................................................................20 
CHAPTER III....................................................................................................................21 
Theoretical Underpinnings of the Project...................................................................21 
Theory to Support Change..........................................................................................22 
CHAPTER IV...................................................................................................................24 
Project Plan.................................................................................................................24 
Evaluation Plan...........................................................................................................26 
CHAPTER V....................................................................................................................29 
Summary of Implementation/Results........................................................................29 
Giving Meaning to the Data.......................................................................................33 
Dissemination and Utilization of Results..................................................................34 
APPENDIX A     DEFINITION OF TERMS..................................................................36 
APPENDIX B     STK CORE MEASUREMENTS........................................................38 
APPENDIX C     ICD 9 CODES.....................................................................................39 
APPENDIX D     STROKE PROTOCOL........................................................................40 
 v 
 
APPENDIX E     CDC FRAMEWORK...........................................................................56 
APPENDIX F     STROKE MAPS..................................................................................58 
APPENDIX G     BRFSS DATA.....................................................................................59 
APPENDIX H     ORGANIZATIONAL CHART...........................................................62 
APPENDIX I     LETTER OF CONSENT.......................................................................63 
APPENDIX J     IRB APPROVAL..................................................................................64 
REFERENCES.................................................................................................................66 
CURRICULUM VITA.....................................................................................................72 
 
 1 
 
CHAPTER I 
Introduction  
The Nevada State Health Division (NSHD) (2011) reports stroke as the third most 
common cause of death in the United States, preceded only by heart disease and cancer. 
There are five leading causes of death in Nevada (NSHD, 2011). These include heart 
disease, cancer, chronic lower respiratory disease, unintentional injuries, and stroke. The 
2008 mortality rate due to stroke in Nevada is reported to be 40.2/100,000 U.S. 
Population (NSHD, 2011). According to the National Vital Statistics Report, 847 
Nevadans died from stroke in 2006, constituting 4.5% of total deaths in Nevada 
(Kochanek, Jiaquan, Murphy, Minino, & Kung, 2011).  In Nevada, approximately 10,000 
people suffer strokes each year that cause significant morbidity and disability (NSHD, 
2011).  
Cardiovascular disorders, primarily strokes, are a major cause of disability and 
contribute to increases in health care costs due to the serious nature of neurological 
emergencies and the often necessary subsequent hospitalization (NSHD, 2011).  Twenty-
nine percent of all strokes are recurrent, and disability commonly manifests as a result. 
Twenty-nine percent of all strokes are recurrent, and disability commonly manifests as a 
result (Urden, Stacy, & Lough, 2009). When cerebral blood vessels become occluded by 
thrombus or embolus, or when intracranial hemorrhage occurs, the brain tissue becomes 
ischemic, resulting in a stroke (Wilson & Giddens, 2008). The key to stroke recovery and 
reducing stroke morbidity, mortality, and disability is through early preventive screening, 
early invention, and treatment (NSHD, 2011).  
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The estimated economic burden of stroke care is greater than $40 billion per year the 
U.S. (McCance & Huether, 2009).  The Milken Institute (2007) released a recent study 
titled, An Unhealthy America: The Economic Impact of Chronic Disease. This study 
provided a report of Nevada’s estimated medical costs for the treatment of stroke. The 
Milken Institute used statistics based on the 2003 Medical Expenditure Panel Survey data 
(NSHD, 2011).  As of 2003, Nevada’s annual cost burden from stroke totaled $700 
million (Milken Institute, 2007). According to the Medical Expenditure Panel Survey 
data for Nevada Medicaid recipients (Milken, 2007, the cost of stroke treatment was 
estimated to be $31.7 million (Nevada Council State Legislatures, 2011).  
There is a pressing need for research specific to Nevada regarding stroke to reduce 
this health disparity in incidence rates and case-mortality rates. The Nevada Integrated 
System of Stroke Prevention identifies three main goals for the prevention, treatment, and 
effective case management of stroke in Nevada. The Nevada Multidisciplinary Team 
(NSHD, 2011) identifies gaps in service by reviewing and evaluating current practices 
and policies. These goals are defined as follows:  
1. Identification of all patients who receive treatment from Nevada emergency 
departments for possible acute stroke;  
2. Promotion and support of quality improvement efforts, interventions, and system 
alterations, and  
3. Systematic collection and analysis of data for the assessment of outcomes 
influenced by intervention (Assam, 2011). 
In this program evaluation, an ischemic stroke protocol in a rural Nevada hospital has 
been evaluated. Ischemic stroke results from low cerebral blood flow (CBF), usually 
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caused by an occlusion of the blood vessel (Urden, Stacy, & Lough, 2009). The occlusion 
can be thrombotic or ischemic. Eighty percent of all strokes are ischemic (McCance & 
Huether, 2009).  
Ischemic strokes are preventable, whereas most thrombotic strokes result from the 
accumulation of atherosclerotic plaque (Urden, Stacy, & Lough, 2009). “Improving the 
quality of stroke care is a global priority, despite the diverse healthcare economies across 
nations” (Joint Commission International, 2010, p. 2). The potential of information 
technology for quality improvement by developing new systems of data collection 
provide additional opportunities to track, trend, and compare stroke performance 
measures (American Heart Association, 2001). The importance of identifying stroke 
information strongly affects the course of events that establish quality of care. Progress 
toward the goal of a structured approach to performance improvement maximizes 
learning of overall practice performance and capabilities while reducing the number and 
severity of stroke symptoms (American Heart Association, 2001).    
The stroke (STK) core measures were developed in collaboration with the American 
Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition 
(BAC) for use by Disease-Specific Care (DSC)-certified primary stroke centers (The 
Joint Commission, 2011).  The collaborative development process was facilitated by the 
expertise and advice of the Disease-Specific Care Stroke Advisory Panel guided by 
direction of the measure specifications with data elements contained in the AHA Get 
With The Guidelines (GWTG)-Stroke patient management tool and the Centers for 
Disease Control and Prevention (CDC) (The Joint Commission, 2011). 
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In health care performance, excellence requires that results are measured, trended, 
and compared with prior performance or best in the industry performance, and that best 
practices are deployed and aligned in a practice or on an organization-wide basis 
(American Heart Association, 2001). A standard set of core performance stroke measures 
can facilitate a common language that promotes benchmarking and sharing of best 
practices (American Heart Association, 2001). The Joint Commission (TJC) (2011) 
adopted and required reporting on the eight stroke (STK) core performance measure set, 
which are often referred to as core measures. Core performance measures are a common 
set of measurement specifications (See Appendix B). Prompted by the requirement that 
stroke core performance measures are reported, this rural Nevada hospital’s stroke 
protocol has been adjusted for compliance with Joint Commission on Accreditation of 
Healthcare Organizations (JACHO). The JACHO is an independent organization that 
accredits and certifies health-care organizations, and makes program recommendations 
that meet the Centers for Medicare and Medicaid Service (CMS) regulations for 
reimbursement. The measure set is applicable to patients with the international 
classification diagnoses of ischemic stroke (See Appendix C) designed to promote 
international comparability in the collection, processing, classification, and presentation 
of mortality statistics (CDC, 2011b). 
Problem Statement 
Initial STK core performance measure data in the third quarter of 2010 reported that 
one out of four stroke patients received venous thromboembolism prophylaxis (VTE), in 
a manner compliant with treatment recommended by JACHO and CMS. The National 
Quality Forum (NQF) a nonprofit organization that operates to improve the quality of 
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healthcare and TJC consider VTE to be the most common preventable cause of hospital-
related death, with an estimated 300,000 VTE-related deaths annually (Michota, 2007).  
This data prompted a need for immediate action including policy adaption and use of 
telemedicine. 
The stroke protocol (See Appendix D) for patients in this rural Nevada hospital was 
initiated for patients reporting to the emergency department with any or all of the 
following eight stroke symptoms: (a) altered state of consciousness; (b) aphasia, or other 
higher cognitive disturbance; (c) dysarthia; (d) facial weakness or asymmetry; (e) lack of 
coordination, weakness, paralysis, or sensory loss of one or more limbs; (f) ataxia, poor 
balance, clumsiness, or difficulty walking; (g) visual loss; and (h) vertigo, double vision, 
unilateral hearing loss, nausea, vomiting, headache, photophobia, or phonophobia. 
The stroke protocol was adapted to serve a rural population without the benefit of 
specialized service providers. The northeastern region of Nevada is without a neurologist. 
Plans for the implementation of the adapted stroke protocol, including the use of 
telemedicine for consultation and examination, were planned for implementation in April, 
2011 as a means of providing medical care. Electronic communication requires the 
acquisition and use of advanced and interactive telecommunication equipment that 
permits direct communication between the patient and the physician at the remote site 
(Centers for Medicare & Medicaid Services, 2010). 
Initial plans for partnership with a Nevada certified stroke center were met with 
difficulty and ultimately failed in an attempt to contract services with a neurologist, 
neurology group, and health care organization. Plans have continued to promote 
partnerships at the local and state level in order to provide quality stroke care to the rural 
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population of northeastern Nevada. There are nine primary stroke centers in Nevada, 
eight in Clark County, and one in Washoe County (NSHD, 2011). The particular rural 
Nevada hospital involved in the study is more than 300 miles from the nearest Nevada 
stroke center (U.S. Census Bureau, 2011a). 
This program evaluation, based on the CDC Framework for Program Evaluation, 
analyzed the start of a new program within a rural Nevada hospital that provided 
information for evaluating the stroke program’s effectiveness, and used information to 
make decisions about program refinement, revisions, and /or continuation (See Appendix 
E). 
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CHAPTER II 
Review of the Literature 
Researchers make the point of explaining the significance of supporting early stoke 
intervention and treatment. The incidence of stroke affects 5,000 people each year, and 5-
14% of the survivors will experience a second stroke within one year of the first stroke 
(McCance & Huether, 2009). Rural populations have been identified as being particularly 
vulnerable to stroke (U.S. Census Bureau, 2011b). The CDC (1999) estimates from the 
National Health Survey that stroke in the United States is 1.45 times more prevalent in 
rural than urban areas. Strong, Mathers, and Bonita (2007) indicate that adherence to 
best-practice stroke care guidelines would reduce the incidence of stroke by 80%. 
However, despite the availability of the National Stroke Guidelines, only 50% of rural 
hospitals are reported to use them (Joubert, et al., 2008). 
Eighty percent of strokes are ischemic, with the three main causes including 
atherosclerotic disease of large extracranial, intracranial vessels, occlusion of intracranial 
vessels by emboli from a cardiac source, and small vessel intracranial occlusive disease 
from hypertension and diabetes (Burke & Laramie, 2004). Ischemic stroke patients 
treated with thrombolytic therapy such as t-PA within three hours of onset experience 
significantly improved outcomes and irreversible neuronal damage (Burke & Laramie, 
2004). Considering that time is of great importance in terms of the reversibility of brain 
ischemia, treatment needs to be initiated promptly (McCance & Huether, 2009).  
Implementation of best-practice recommendations for stroke management in rural 
areas is often suboptimal (American Heart Association, 2008). The quality of stroke 
services for rural patients is variable with contributing factors that can include difficult 
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terrain, long distances to hospitals, poor transportation and communications, traditional 
practices, lack of medical services and personnel, and lack of equipment, lack of 
hospitalization, and financial support (American Heart Association, 2008). 
Organizations such as the American Evaluation Association (AEA) are devoted to the 
application and exploration of program evaluation, personnel evaluation, technology, and 
many other forms of evaluation. The AEA (2008) believes that “evaluation involves 
assessing the strengths and weaknesses of programs, policies, personnel, products, and 
organizations to improve their effectiveness” (p. 7). Additionally, the AEA (2008) 
advises that program evaluation increases and promotes use of evaluation data, while 
contributing to theory and knowledge development of effective human action. Program 
evaluation is an essential organizational practice in public health, however, it is not 
practiced consistently across program areas, nor is it well-integrated into the day-to-day 
management of most programs (CDC Evaluation Working Group, 2008). Program 
evaluation is also necessary to fulfill CDC's operating principles for public health, which 
include using science as a basis for decision-making and action, expanding the quest for 
social equity, performing effectively as a service agency, making efforts outcome-
oriented, and being accountable (CDC Evaluation Working Group, 2008). This analysis 
establishes and creates research credibility for program evaluations. 
The CDC Evaluation Working Group suggests that evidenced based research, 
particularly in program evaluation, is important for its management and improvement. 
Additionally, this working group identified the need for the development of plans, 
partnerships, and feedback systems that provide a path for learning and ongoing 
improvement (CDC Evaluation Working Group, 2008).  
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The CDC Framework for Program Evaluation is described as a “driving force for 
planning effective strategies, improving existing programs, and demonstrating the results 
of resource investments” (U.S. Department of Health and Human Services, 1999, p. 1). 
The recommended framework facilitates an integration of program evaluation that can be 
used to promote health and prevent disease and injury. The U.S. Department of Health 
and Human Services (1999) describe the CDC Framework for Program Evaluation as 
applicable to almost any organized public health activity including systems, policy 
development activities, outbreak investigations, laboratory diagnostics, communication 
campaigns, infrastructure building projects, training and educational services, and 
administrative systems. 
In 2003, the CDC Framework for Program Evaluation was used to assess tuberculosis 
contact investigation programs in Massachusetts. In this program evaluation three of the 
six steps of the CDC’s framework were utilized to engage and identify stakeholders, 
create a logic model describing the tuberculosis program components, and develop self-
evaluation tools. Conclusion findings credit the CDC framework with providing a useful 
methodology for beginning the assessment of tuberculosis contact investigation programs 
with findings used to target areas in need of improvement (Boutotte, Wilce, & Etkind, 
2003). 
In 2005, the Diabetes Primary Prevention Initiative Interventions Focus Area 
implemented the CDC Framework for Program Evaluation in five state-level diabetes 
prevention and control programs to translate diabetes primary prevention trails 
(Porterfield, Hinnant, Stevens, & Moy, 2005). Evaluation findings summarized 
recommendations for future community-based diabetes prevention initiatives, and 
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identified the need to strengthen clinical-community partnerships for the referral of 
people to evidence-based lifestyle programs (Porterfield, Hinnant, Stevens, & Moy, 
2010). 
In 2010, New York State Department of Health announced plans to eliminate 
childhood lead poisoning by developing and implementing an evaluation of the lead 
elimination plan. The CDC Framework for Program Evaluation was chosen as the design 
for the evaluation, and will be utilized to measure progress, accomplishment of specific 
plan components, overall coordination of plan efforts, and statewide outcomes (New 
York State Department of Health, 2010). Evaluation findings will be used to refine and 
improve the elimination plan.   
As can be seen the CDC framework contributes to the achievement of research that is 
useful in program evaluation processes. Program evaluation can emerge from a variety of 
sources and settings all of which have an emphasis on the significant usefulness and 
importance of evidenced based practice to generate positive outcomes. 
Needs Assessment  
The Department of Health and Human Services Centers (DHHS) for the CDC Heart 
Disease and Stroke maps the applications of data for heart disease and stroke mortality 
and hospitalization rates. This application allows for the visualization of national, state, 
and county rates for stroke mortality and resulting hospitalizations (See Appendix E & 
F). Nevada state statistics report stroke death rates from 2000-2006 as 94% of the total 
population of 35 year olds and older (totaling1,269,670), compared to the national stroke 
death rate of 98%. Elko County Nevada is reported as having one of the lowest stroke 
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hospitalization rates in the state, although has the second highest stroke mortality rate in 
the state (CDC, 2011a).  
Casper, Wing, Anda, Knowles, and Polland (2011) list the disease determinants for 
stroke as: 
1. Medical diagnosis 
• Hypertension 
• Hyperlipidemia 
• Cardiovascular disease 
• Diabetes mellitus 
• History of stroke or transient ischemic attack 
• Hematological disorder 
2. Individual lifestyle and behaviors 
• Smoking 
• Alcohol consumption 
• Sedentary lifestyle  
• Inadequate nutrition 
3.  Genetic predisposition includes 
• Family history of heart disease, high blood pressure, and stroke 
• Gender: At a younger age men are at a higher risk of stroke than women. At 
an older age female are more likely to have a stroke than men.  
• Race/ethnicity: At a younger age African Americans, Hispanics, and 
American Indian/Alaska Natives are more likely to a have a stroke than non-
Hispanics, Asians or Caucasians (Casper, et al., 2011). 
 12 
 
The NSHD (2011) report gives a descriptive analysis of the epidemiology of stroke in 
Nevada. Other sources of analysis include Nevada Behavioral Risk Factors Surveillance 
Survey (BRFSS), and Centers of Disease Control and Prevention (CDC). The stroke 
prevalence and frequency rates were analyzed in accordance with age groups, gender, 
race/ethnicity, and educational level by BRFSS. Members of the population aged 18 
years and older were selected for the analysis. According to the data, the stroke 
prevalence differed in relation to racial/ethnic groups, education level, and income level. 
The incidence of stroke is higher in the aged population. The 65 and older age group 
demonstrated a higher prevalence of stroke than the group of persons aged 18-44 years. 
The number of women having had a stroke have a longer life expectancy than that of men 
(Assam, 2011). 
A lower stroke prevalence rate was seen in the more highly educated portion of the 
population, as compared to the portion of the population with less than a high school 
education. Stroke was also observed to occur more frequently among African Americans 
(4.7%) than Hispanics (0.77%) and Caucasians (2.63%). There was a significant 
difference in stroke prevalence observed in different areas of Nevada (NSHD, 2011).  
Research provides important contributory data to further understand and clarify this 
health disparity in relation to demographics of the defined population. 
Population identification. As of the 2009 census, the population of Elko County, 
Nevada was 47,896 with 15,638 households, and 11,493 families residing in the county 
(U.S. Census Bureau, 2011a). The U.S. Census Bureau defines rural as a term of 
exclusion (American Heart Association, 2008). Elko, County, Nevada has a land area of 
17,179.03 square miles with 2.6 persons per square mile (U.S. Census Bureau, 2011a). 
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This rural Nevada hospital is located in Elko, Nevada, which is 300 miles east of Reno, 
Nevada, 240 miles west of Salt Lake City, Utah, and 250 miles south of Boise, Idaho. It 
is important to understand that areas in rural Nevada surrounding Elko lack accessible 
healthcare services and specialty care is very limited. Maintaining an optimal level of 
care is crucial because stroke patients in the rural Nevada area access services through 
this hospital’s emergency room. 
Prior to the start of the third quarter of 2010, stroke evaluation and treatment was left 
to the discretion of the emergency room physician, and included air transport time of a 
minimum of one hour to the nearest facility providing neurological care. In the past 
methods used to provide stroke care services, lacked a standard set of clinical measures 
for providers, health systems, and payers used to monitor the quality of care (American 
Heart Association, 2001). As the health care system has changed with the demand of high 
quality standards, so has this rural Nevada hospital’s search for ways to deliver care and 
simultaneously gain efficiency. 
Identification of project sponsor and key stakeholders. The stroke protocol is 
funded by the rural Nevada hospital and directs the evaluation of stroke patients in hopes 
of the institution of rapid, informed guideline protocols. Additional stakeholders include 
clinical professionals and health care consumers. This organizational chart is available in 
Appendix H. 
Organizational assessment. The roles of organizations endeavoring to create a 
culture of quality and continuous improvement cannot be underestimated (Baker, 2009). 
At the prompting of mandatory reporting of stroke core performance measures this rural 
Nevada hospital’s stroke protocol has been adjusted to accommodate Joint Commission 
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on Accreditation of Healthcare Organizations (JACHO) recommendations, and to meet 
Centers for Medicare and Medicaid Service (CMS) regulations for reimbursement. 
Mandatory reporting and potential loss of reimbursement for care if noncompliant with 
evidence based practice STK measures prompted a need for immediate action including 
policy adaption. 
Assessment of available resources. Hospital privilege has been granted to 
participate in the review and gathering of Stroke Core Performance Measures which 
consists of CMS reportable data as part of continuous quality improvement. 
Team selection and formation. Consideration was given regarding organizational 
team activities designed to generated the best outcomes, acknowledging the six basic 
roles in a quality improvement team: team leader, team member, recorder, timekeeper, 
quality advisor, and executive champion. The nursing quality director was charged with 
the task of developing a process to adapt a stroke protocol that would meet mandatory 
compliance recommendations for reimbursement. The team members included managing 
information technology, nursing supervisors and nursing directors from the emergency 
room, medical, surgical, pediatric, obstetrics, and intensive care unit. The Chief Nursing 
Officer and Quality Director served as the executive champions.  
Cost benefit analysis.  Economics of health care delivery are the lifeline for health 
care organizations and providers. The estimated economic cost of stroke care is greater 
than $40 billion per year (McCance & Huether, 2009). According to Medical Expenditure 
Panel Survey data for Nevada Medicaid recipients the price of stroke was estimated to be 
$31.7 million (NSHD, 2011). Knowledge of the current and expected quality measures 
for compliance with Continuous Quality Improvement (CQI) positively improves care 
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and controls cost (McLaughlin & Kaluzny, 2006). Pressure to increase quality and lower 
costs is coming from accreditation agencies, the public, the media, insurers, and 
governmental agencies (McLaughlin & Kaluzny, 2006.) The Patient Protection and 
Affordable Care Act (PPACA) of 2010, better known as healthcare reform, was designed 
to change our health delivery system. A major challenge affecting healthcare 
organizations and providers is the implementation of new payment models. Health reform 
moves healthcare organizations and providers from the traditional fee-for-service 
environment to an accountable care environment that ties reimbursement to quality. This 
does several things; it increases quality, decreases costs, and pays for performance 
(Christensen, Grossman, & Hwang, 2009). The accountable care model/delivery payment 
system requires healthcare organizations to be responsible for coordinating care to 
improve patient outcomes. Healthcare organizations are held accountable for the care 
they give and reimbursement is impacted by the quality of care delivered.  
Accountable Care Organizations (2009) describe a growing consensus of efforts to 
improve care and foster greater accountability for both quality and cost and include 
several guiding principles for reform, such as require local accountability, allow for 
variation in strategies that local health care systems use to improve care, and promote 
improved care at a lower cost. 
Stroke core measures provide evidence based patient care that is shown to produce 
the best outcomes. Organizational fiscal needs are based on service growth and intensity. 
Compliance data is publicly reported. Quality has become an important component in the 
evaluation of healthcare organizations and is necessary to reduce avoidable complications 
and unnecessary costs. Sustainable growth is achieved through quality care. Voluntary 
 16 
 
reporting of data allows for maximum reimbursement. Efforts to measure and improve 
quality are what make CQI successful. 
Defining the scope of the project. This program evaluation based on the CDC 
Framework for Program Evaluation is used to analyze the start of a new program within a 
rural Nevada hospital to produce information for evaluating the stroke program’s 
effectiveness and to use this information to make decisions about program refinement, 
revisions, and /or continuation. 
Project evaluation questions. A set of 10 Stroke (STK) performance measures 
derived from published care guidelines and clinical trials. Eight of the 10 measures 
received endorsement and inclusion by the National Quality Forum (NQF) and CMS as 
evidenced-based measures of care. All measures were adopted except STK-7 dysphagia 
screening and STK-9 smoking cessation. Although swallowing assessment is important 
for many patients for the prevention of aspiration pneumonia, dysphagia screening was 
not endorsed by the NFQ because the screenings are currently not well defined and use 
varying techniques, lack of a valid, reliable, standardized screening tool or process that is 
supported by research, and the reviewed literature showed that 50% of African 
Americans were under represented (LaBresh, 2008). Smoking cessation is a core 
performance outcome measure for hospitals that mandates the documentation of the 
tobacco-use status of all admitted patients (The Joint Commission, 2011). Hospital are 
required to provide both cessation counseling and medication during hospitalization for 
all identified tobacco users.  
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Evaluation questions include the Stroke (STK) Core Performance Measure Set: 
• STK-1 Venous Thromboembolism (VTE) prophylaxis 
• STK-2 Discharged on antithrombotic therapy 
• STK-3 Anticoagulation therapy for atrial fibrillation/flutter 
• STK-4 Thrombolytic therapy 
• STK-5 Antithrombotic therapy by end of hospital day 2 
• STK-6 Discharged on statin medication 
• STK-8 Stroke education 
• STK-10 Assessed for rehabilitation 
Policy implications. Hospitals that participate with Medicare and Medicaid services 
are required to successfully undergo Joint Commission accreditation. Healthcare payors 
expect hospitals providing services to not only comply with controls and standards but to 
also furnish measurable assurance (Joint Commission International, 2010). 
If the patient onset is within two hours of arrival, the patient must have thrombolytic 
treatment within one hundred eighty minutes of onset or the healthcare facility must 
provide a documented contraindication. Thrombolytic therapy is the use of drugs to break 
up or dissolve blood clots, which are the main cause of stroke (National Institutes of 
Health, 2011). Venous Thromboembolism Prophylaxis (VTE) must be administered the 
day of admission or the day after for non-ambulatory patients or a documented 
contraindication. Ischemic stroke patients must have antithrombotic therapy administered 
by end of day two or a documented contraindication. Patients must be assessed for 
rehabilitation services or a documented contraindication. Stroke/Transient Ischemic 
Attack (TIA) patients are required to have neurological checks every two hours for 
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assessment of neurological deficits. Low-density lipoprotein (LDL) must be measured in 
the first 48 hours of arrival. Antithrombotic therapy must be prescribed at discharge or a 
documented contraindication. Patients with atrial fibrillation/flutter a cardiac irregularity 
must have anticoagulation therapy to decrease the risk of developing a blood clot at 
discharge or a documented contraindication. Ischemic stroke patients with an LDL 
greater than or equal to 100mg/dl, or LDL not measured or patients who were on lipid 
lowering medication prior to hospital arrival need to be discharged on a HMG-CoA 
Reductase Inhibitor (Statins) medication or a documented contraindication. Statins 
decrease blood clot formation. There are several instances when statins are 
contraindicated such as with active liver disease and during pregnancy (Arcangelo & 
Peterson, 2006). 
Procedure. 
• Step one: Engage key stakeholders such as those involved in program operations, 
those served or affected by the program, and those who are intended users of evaluation 
findings (U.S. Department of Health and Human Services, 2005). Obtain a formal letter 
of hospital approval for evaluation of stroke program (See Appendix G). The program 
stakeholders include the hospital, clinical professionals, and health care consumers. 
Create an established organizational chart (See Appendix H). 
• Step two: Describe the program with a comprehensive description clarifying need, 
targets, outcomes, activities, and resources. (U.S. Department of Health and Human 
Services, 2005). Standards of accuracy and propriety apply most directly to describing 
the program (U.S. Department of Health and Human Services, 2005). This program 
evaluation describes program strategies over the third and fourth quarters of 2010 as well 
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as the first, second, and third quarters of 2011, that have been and will be initiated to 
reduce the burden of neurological disease with the application of a stroke protocol that 
complies with defined goals for the assessment and management of stroke victims. 
• Step three: Focus the evaluation design with stakeholders to define purpose and 
uses of evaluation (U.S. Department of Health and Human Services, 2005). Application 
of the Centers of Disease Control (CDC) Framework for Program Evaluation will answer 
questions by selecting evaluation strategies that are useful, feasible, ethical, and accurate. 
• Step four: Gather credible evidence including consideration of indicators, sources 
of evidence/ methods of data collection, quality, quantity, and logistics (U.S. Department 
of Health and Human Services, 2005). The program evaluator, with the assistance of the 
hospital’s utilization review board, will select patient charts at the end of each quarter 
based on the ICD code table for stroke diagnoses. For the purpose of this program 
evaluation, Starla Ricks MSN, FNP-BC will function as the program evaluator.  The 
Stroke Core Performance Measures which consists of Joint Commission & CMS 
reportable data, which will be abstracted to determine whether measures have or have not 
been met. Data abstraction will take place following the last day of the previous quarter. 
Compilation of data and interpretation of data based on stroke performance measures. 
• Step 5: Justify conclusions by “analyzing the evidence, making claims about the 
program based on the analysis, and justifying the claims by comparing the evidence 
against stakeholder values” (U.S. Department of Health and Human Services, 2005). 
Compare quarterly core performance measures. 
• Step 6: Ensure use of evaluation findings and shared lessons learned to improve 
program. Five elements important to usefulness include providing recommendations, 
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preparation, feedback, follow up, and dissemination (U.S. Department of Health and 
Human Services, 2005). Final evaluation of program based on data findings. Standards of 
utility, propriety, and accuracy most directly relate to ensuring use and sharing lessons 
learned (U.S. Department of Health and Human Services, 2005). 
Mission, Goals, and Objectives Statements 
This program evaluation of stroke protocol in a rural Nevada hospital evaluates a 
systematic way to improve and account for actions that involve procedures that are 
useful, feasible, ethical, and accurate. Compliance with defined goals for assessment and 
management are essential in the determination of financial reimbursement for care within 
this practice setting. Application of the Centers of Disease Control (CDC) Framework for 
Program Evaluation answers questions by selecting evaluation standards that are useful, 
feasible, ethical, and accurate. The logic, reasoning, and values of evaluation that are 
reflected in this framework can lead to lasting impacts, such as basing decisions on 
systematic judgments instead of unfounded assumptions. The specific aim of this project 
is to analyze the start of a new program within a rural Nevada hospital to produce 
information for evaluating the stroke program’s effectiveness and to use this information 
to make decisions about program refinement, revisions, and /or continuation. The key to 
stroke recovery is through early intervention and treatment. 
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CHAPTER III 
Theoretical Underpinnings of the Project 
The recommended Framework for Program Evaluation is the Centers of Disease 
Control (CDC) model of program evaluation [see Appendix E] (Mateo & Kirchhoff, 
2009).  The CDC model was constructed to ensure that amid the complex transitions in 
health care, program directors, sponsors, and leaders remain accountable and committed 
to achieving measurable health outcomes (Billings, 2000; CDC Evaluation Working 
Group, 2008; Boutotte, Wilce, & Etkind, 2003). 
Mateo and Kirchhoff’s (2009) describe the Framework for Program Evaluation as a 
practical, non-prescriptive tool, designed to summarize and organize the essential 
elements of program evaluation. The Framework for Program Evaluation is useful when 
performing program evaluations. After data are collected, findings will be reviewed, and 
the degree to which criteria was met will be evaluated. Expected standards of program 
evaluation hinge upon four core concepts, which are central to the framework: utility, 
feasibility, propriety, and accuracy (Mateo & Kirchhoff, 2009). 
Underlying the CDC Framework for Program Evaluation are the five guiding 
principles of systematic inquiry, competence, integrity and honesty, respect for people, 
and commitment to public welfare, and are adapted from the CDC 1999. The American 
Evaluation Association (2008) proposes that such principles guide professional 
evaluation and are clearly defined to the public.  
Major concepts described in the CDC Framework for Program Evaluation are used to 
describe the program evaluation steps (CDC Evaluation Working Group, 2008). Steps for 
formative and summative evaluation include engaging stakeholders, describing the 
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program, focusing the evaluation plan, gathering credible evidence, and justifying 
conclusions. 
Theory to Support Change 
In healthcare, the real goal is to always provide better patient care. Change potentiates 
the possibility of accomplishing this goal. Decisions about the quality of clinical 
outcomes take into account quality concern, improvement opportunities, and whether 
there is evidence to support considering a change. Hinshaw and Grady (2011) reminds us 
that despite the knowledge that evidence-based practice (EBP) improves healthcare 
quality and reduces morbidities, mortality, costs, and geographic variation of healthcare 
services, it is not standard practice in numerous health systems across the United States. 
Hinshaw and Grady (2011) further elaborate on the viewpoint that “many clinicians 
in a multitude of settings across the care continuum continue to deliver care to their 
patients based upon tradition, information that was learned years before in their 
educational programs, and outdated policies and procedures that exist in institutions” (p. 
87). Change is required when implementing a continuous quality improvement initiative 
(Zaccagnini & White, 2011).   
One of the earliest and perhaps the most useful change method theories is Lewin’s 
(1951) force-field model that identified three phases of change: first, unfreezing, in which 
people are preparing for change; second, moving, in which people have accepted the need 
for a change and actually engage in the change, and third, refreezing, in which the new 
change is integrated into the system and becomes part of the new norm or culture.  
Lewin’s (1951) change method theory points out that human behavior is variable among 
individuals or groups based on their environment at any particular time. Lewin (1951) 
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focused on social change, pointing out that “group life is never without change, merely 
difference in amount and time and type of change exist” (p. 199). Lewin’s (1951) field 
theory proposes maintaining the status quo, or a state of equilibrium, when restraining 
forces and driving forces balance each other. To achieve change, the restraining forces 
must be weakened and the driving forces strengthened (Kearney, 2001). Increasing 
incentives with the use of position power to force change is one approach to increase the 
driving forces that achieve change (Yukl, 2010). Restraining forces maintain the status 
quo and resist change. They include norms, values, relations among people, morals, fears, 
perceived threats, and regulations (Kearney, 2001).  Reducing fear or failure, economic 
loss, or removing opponents reduce restraining forces that create resistance to change 
(Yukl, 2010). Driving forces support change, and include the desire to please or the 
desire for new, effective, or efficient activities (Kearney, 2001). System imbalance 
becomes the impetus for change (Kearney, 2001). 
While all these changes in quality improvement and reporting based on compliance 
with STK measures initially seemed overwhelming, the outcome enhanced the care 
delivered to stroke patients.  
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CHAPTER IV 
Project Plan  
The steps and procedures in the CDC Framework for Program Evaluation have been 
used for the evaluation of the stroke patient care program (see Appendix C). Program 
improvement was the focus of the evaluation. Mateo & Kirchhoff’s (2009) suggest that 
program staff is trained to identify disparities between program objectives and the needs 
of the target population.  Also, discrepancies between program implementation and 
program plans should be identified and addressed.  The final disparity that can be 
identified is one that may exist between the expectations of the target population and the 
services actually delivered.  Identification of three of these discrepancies is vital in order 
to provide ongoing information to the program.   
Setting. This rural hospital provides regional healthcare services to the second largest 
county in the state (U.S. Census Bureau, 2011b). This rural Nevada is the only hospital in 
this services area and borders Idaho on the north and Utah on the east. Elko is 300 miles 
east of Reno, 240 miles west of Salt Lake City, and 250 miles south of Boise. 
Population of interest. The population is defined as a collection of patients sharing a 
common set of universally measured characteristics of ICD-9 CM principle diagnosis of 
ischemic stroke.  
Measures/instruments/activities. The steps in the CDC framework provide a 
fundamental set of standards of utility, feasibility, propriety, and accuracy for program 
evaluation (U.S. Department of Health and Human Services,2005). The CDC standards 
are used in each step of the CDC framework as a guide to keep options of evaluation 
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manageable by identifying credible evidence that is the most useful (U. S. Department of 
Health and Human Services, 2005). For a look at evaluation standards, see Appendix E. 
Domains of performance include appropriateness, continuity, effectiveness, 
prevention/early detection, and timeliness. Measurement of related outcomes include: 
mortality, decreased mortality, readmissions within 30 days, decreased reliability, 
increased delivery of evidence-based care, and improvement noted as increase in rate. 
Timeline. 
April 2011 
• Defense of capstone proposal 
• Revisions to proposal  
April – September 2011 
• Gather credible evidence: Data collection of stroke core performance 
measures using a retrospective method for review of the second and third 
quarters of the year.  
October – December 2011 
• Justify conclusions: Data analysis, interpretation, and recommendations 
January – March 14, 2012 
• Ensure use and share lessoned learned 
• Completion of program evaluation report 
March 29, 2012 
• Defend Capstone Project 
Resources. The most important component of the program evaluation has been 
access to data. No funding was necessary for program evaluation completion. As an 
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employee of the hospital, privilege was granted to participate in the review and the 
gathering of Stroke Core Performance Measures, which consists of reportable data as part 
of continuous quality improvement. 
IRB approval. In this program evaluation of stroke protocol in a rural hospital, 
research activities posed no risk to subjects. However, ethical considerations should be 
deliberated with any research activity involving human -subjects for research. “As the 
lines between quality improvement activities and research blur, the tendency for these 
projects to undergo review by IRBs is stronger than in the past” (Zaccagnini & White, 
2011, p. 456). The application for Internal Review Board (IRB) approval was completed 
as required and.  This program evaluation received exempt status from the University of 
Nevada Las Vegas. 
Evaluation Plan 
Step one: Engage key stakeholders, such as those involved in program operations, 
those served or affected by the program, and those who are intended users of evaluation 
findings (U.S. Department of Health and Human Services, 2005). A meeting with 
stakeholders took place to clarify the intent of the evaluation and a formal letter hospital 
approval was acquired to evaluate the stroke program (see Appendix G).   
Step two: Describe the program with a comprehensive description that clarifies need, 
targets, potential outcomes, implementation, and resources. (U.S. Department of Health 
and Human Services, 2005). The methods for sampling, data collection, data analysis, 
interpretation, and judgment were described. This program evaluation describes program 
strategies over the third and fourth quarters of 2010, as well as the first, second, and third 
quarters of 2011, that have been initiated in order to reduce the burden of neurological 
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disease with the application of a stroke protocol that complies with defined goals for the 
assessment and management of stroke victims.  
Step three: Focus the evaluation design with stakeholders to define the purpose and 
potential applications of evaluation (U.S. Department of Health and Human Services, 
2005). The Application of the Centers of Disease Control (CDC) Framework for Program 
Evaluation offered a focused approach to answer evaluation questions with the STK 
measure set that the stakeholders agreed were useful, feasible, ethical, and accurate 
Step four: Credible evidence was gathered through the consideration of indicators, 
sources of evidence/ methods of data collection (U.S. Department of Health and Human 
Services, 2005). The program evaluator, with the assistance of the hospital’s utilization 
review board, selected patient charts at the end of each quarter based on the ICD code 
table for stroke diagnoses (See Appendix C).  For the purpose of this program evaluation, 
Starla Ricks MSN, FNP-BC functioned as the program evaluator.  The Stroke Core 
Performance Measures, which consist of Joint Commission & CMS reportable data, were 
abstracted to determine whether measures have or have not been met. Data abstraction 
took place following the last day of the previous quarter. Subsequently, all data compiled 
and interpreted was based on stroke performance measures. 
Step 5: Justify conclusions by “analyzing the evidence, making claims about the 
program based on the analysis, and justifying the claims by comparing the evidence 
against stakeholder values” (U.S. Department of Health and Human Services, 2005, 
p.16). Analysis and synthesis of quarterly STK core performance measure findings pre 
and post protocol detected patterns in evidence.  
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Step 6: Ensure use of evaluation findings and shared lessons learned in order to 
improve the program. Relevant recommendations, proper preparation, feedback, follow-
ups, and the dissemination of information are all essential components of program 
applicability (U.S. Department of Health and Human Services, 2005). Perform final 
evaluation of the program based on data findings. Standards of utility, propriety, and 
accuracy most directly relate to ensuring use and sharing lessons learned (U.S. 
Department of Health and Human Services, 2005). The justified evaluation conclusions 
are based on the evidence including standards, analysis and synthesis, interpretation, 
judgment, and recommendations. 
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CHAPTER V 
Summary of Implementation/Results 
Initiation of the project. The Joint Commission (2010) Specification Manual for 
Joint Commission National Quality Core Measures defines the population and sampling 
specifications: The population was defined as a collection of patients sharing a common 
set of universally measured characteristics that included ICD-9-CM Diagnosis, and the 
sample size requirements determined the number of cases to sample. In order to achieve a 
representative sample of the patient population there needs to be a fairly large number of 
cases to sample.  In this rural hospital the average quarterly patient population equaled a 
patient population size of 7.8 which necessitated collecting data for the entire population. 
Threats and barriers to the project. There were challenges faced by this rural 
hospital that included resistance from the physicians to the changes being implemented. 
At this rural hospital, physicians referred to the new protocol for STK core performance 
measure compliance as “cookbook medicine,” and argued that adhering to quality 
guidelines detracted from their ability to use their own judgment and experience. The 
rural hospital addressed these concerns in several ways, including naming the hospitalist 
as physician champion to communicate and coordinate the change efforts among 
physician colleagues. At the same time, physicians and hospital clinical staff received 
education on the evidence-based research behind the measures and the importance of 
compliance necessary to ensure that they achieve high standards of care. 
Monitoring of the project. The hospital samples were monitored to ensure that 
sampling procedures consistently produced statistically valid and useful data. Detailed 
measure specifications, including population identifiers, inclusion and exclusion criteria, 
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and data element definitions were associated with each of the Stroke (STK) performance 
measures. 
Data collection. Stroke programs should be collecting data for eight of the 
standardized stroke (STK) measures (Joint Commission, 2010). Data collection includes 
eight standardized measures on a quarterly basis with the provision that monthly data 
points are gathered and reported. Data was collected through patient chart abstraction 
using ICD code tables of stroke measures. This program evaluation includes retrospective 
data sources for administrative data and medical records. 
The measure set is applicable to patients with diagnosis of ischemic stroke. The 
numerator within the stroke performance measure is the number of stroke patients that 
receive treatment within the guidelines of the stroke performance measure. The 
denominator is the number of stroke patients in total. Exclusions to the population 
include patients younger than 18 years of age, patients who left against medical advice, 
patients who expired, and patients admitted for the performance of elective carotid 
intervention. 
• STK-1: Venous Thromboembolism (VTE) Prophylaxis 
Numerator: Ischemic or hemorrhagic stroke patients who received VTE prophylaxis 
or have documentation why no VTE prophylaxis was given on the day of or the day after 
hospital admission 
Denominator: Ischemic stroke patients 
• STK-2: Discharged on Antithrombotic Therapy 
Numerator: Ischemic stroke patients prescribed antithrombotic therapy at hospital 
discharge 
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Denominator: Ischemic stroke patients 
• STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter 
Numerator: Ischemic stroke patients prescribed anticoagulation therapy at hospital 
discharge 
Denominator: Ischemic stroke patients with documented atrial fibrillation/flutter 
• STK-4: Thrombolytic Therapy 
Numerator: Acute ischemic stroke patients for whom thrombolytic therapy was 
initiated at this hospital within 3 hours (< 180 minutes) of identification signs of stroke  
Denominator: Acute ischemic stroke patients whose time of arrival is within 2 hours 
(< 120 minutes) of identification signs of stroke  
• STK-5: Antithrombotic Therapy by End of Hospital Day 2 
Numerator: Ischemic stroke patients who had antithrombotic therapy administered by 
end of hospital day 2 
Denominator: Ischemic stroke patients 
• STK-6: Discharged on Statin Medication 
Numerator: Ischemic stroke patients prescribed statin medication at hospital 
discharge 
Denominator: Ischemic stroke patients with an LDL > 100 mg/dL, OR LDL not 
measured, OR who were on a lipid-lowering medication prior to hospital arrival 
• STK-8: Stroke Education 
Numerator: Ischemic or hemorrhagic stroke patients with documentation that they or 
their caregivers were given educational material addressing all of the following: 
1. Activation of emergency medical system 
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2. Need for follow-up after discharge 
3. Medications prescribed at discharge 
4. Risk factors for stroke 
5. Warning signs for stroke 
Denominator: Ischemic stroke patients discharged home 
• STK-10: Assessed for Rehabilitation 
Numerator: Ischemic or hemorrhagic stroke patients assessed for, or who received 
rehabilitation services 
Denominator: Ischemic stroke patients 
Data analysis. Data was analyzed using the statistical package for the social sciences 
(SPSS).  Data analysis included log-linear regression of one hundred percent of the 
quarterly initial patient population of ischemic stroke cases. 
 To assess whether the stroke protocol was significant in increasing the number of 
correctly diagnosed patients, a log-linear regression analysis was conducted. Combining 
the two pre-protocol quarters data (3rd and 4th quarters of 2010) and comparing that to the 
three post-protocol quarters data (1st, 2nd, and 3rd quarters of 2011), the interaction 
between pre and post-protocol diagnoses was significant, Z = 3.28, p = .001. The 
parameter estimate (.429) indicated an odds ratio of 1.54 which can be interpreted as 54% 
increase, or, in other words, patients were 54% more likely to be diagnosed correctly 
after the stroke protocol was implemented. Further assessment of the individual STK 
measures showed that four of the eight measures (STK 7 and STK 9 were not used in this 
evaluation) significantly differed from pre-protocol to post-protocol: a binomial test 
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indicated that STK 1 (p = <.0005), STK 2 (p = <.0005), STK 6 (p = <.0005), and STK 8 
(p = <.0005) all significantly increased at an alpha level of p = .025 (one tailed test). 
 
Table 1     Results 
STK 
Measure 
Diagnosed/Total     
(Pre-protocol) 
% Diagnosed 
(Pre-
protocol) 
Diagnosed/Total     
(Post-protocol) 
% Diagnosed 
(Post-protocol) 
1 3/7 43% 15/16 94% 
2 7/8 88% 13/13 100% 
3 1/1 100% 2/2 100% 
4 0/1 0% 0/1 0% 
5 6/7 86% 13/14 93% 
6 1/3 33% 6/6 100% 
8 1/6 17% 5/8 63% 
10 8/8 100% 14/14 100% 
 
 
Giving Meaning to the Data 
Log-linear regression is used for assessing relationships where the dependent variable 
is dichotomous. Logistic regression is useful when at least one of the independent 
variables is continuous whereas log-linear regression is typically used when both the 
independent and dependent variables are dichotomous. The individual comparisons of the 
STK measures were limited sample sizes and the outcome was dichotomous. It was not 
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possible to do a repeated measures t-test. The binomial test uses a binomial distribution 
and is useful for comparing two proportions or counts, which is applicable to this study. 
To see if the percentages were significantly different the binomial test compared the 
number of patients who were diagnosed correctly vs. incorrectly to the proportion of 
successes prior to the protocol. Suggestions to further examine the individual protocols 
would be to collect more data so that one could at least use a normal approximation rather 
than the binomial distribution to assess differences. 
Descriptive statistics were used to describe sample characteristics and frequencies 
including gender, age, and Ferri’s (2011) risk factors for ischemic stroke including 
diabetes mellitus, hypertension, smoking, family history of premature vascular disease, 
hyperlipidemia, atrial fibrillation, history of TIA, history of recent myocardial infarction, 
and history of congestive heart failure. Descriptive statistical findings were as such: 14 
males, 25 females, ages 44 years-of-age to 92 years-of-age, 12.8% of the patients had 
diabetes mellitus, 25% of the patients had hypertension, 7% of the patients smoked or had 
a history of tobacco use, 5% of the patients had a history of recent myocardial infarction, 
and 23% had a history of congestive heart failure. 
Dissemination and Utilization of Results 
The goal for dissemination is to achieve full disclosure and impartial reporting that 
ensures that the stakeholders are aware of the evaluation procedures and findings (CDC, 
1999) An essential step in program evaluation is writing an evaluation plan and 
disseminating the report is to stakeholders (Mateo & Kirchoff, 2009). A plan to provide a 
program evaluation report of the results of the project has been discussed and agreed 
upon with the stakeholders. The program evaluation report ensures that the information 
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needs of relevant audiences will be met.  Mateo and Kirchoff (2009) describe the 10 
components of the program evaluation report which will include the purpose of the 
report; the nature of the clinical program and its components parts; the setting of the 
program; the time frame for the program; the program staff resources used; the way the 
data obtained during the formative evaluation were used to alter the program and improve 
its implementation process; the evaluation methods used, including the evaluation of the 
program process and outcome variables; results of data analysis; recommendations for 
program revisions, refinement, and continuation; and a summary of the program’s overall 
effectiveness in achieving its designed purpose.  
 By applying the principles of the CDC framework into the program evaluation of 
stroke protocol in a rural Nevada hospital both the procedures used and the lessons 
learned from the evaluation can be utilized  as a driving force for improving the existing 
stroke care and account for health promotion and disease intervention. The stroke 
protocol was significant in increasing the number of correctly diagnosed patients and 
assessment of the individual STK measures showed that four of the eight measures 
significantly differed from pre-protocol to post-protocol. 
  The systematic use of this stroke protocol supported the use of evidence-based 
practice guidelines and improved compliance with standards. The stroke protocol must be 
kept current to incorporate subsequent scientific evidence. Given this research 
perspective, the program evaluation, with a population perspective and ensuing data 
analysis, serves to provide further relevant data engaged in the pursuit of lessening this 
health care disparity.  
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APPENDIX  A 
DEFINITION OF TERMS 
PROGRAM EVALUATION DEFINITIONS 
U.S. Department of Health and Human Services, 2005 
Program evaluation: The systematic collection of information about the activities, 
characteristics, and outcomes of programs to make judgments about the program, 
improve program effectiveness, and/or inform decisions about future program 
development.   
Stakeholders: People or organizations that are invested in the program or that are 
interested in the results of the evaluation. Stakeholders include organizations, hospitals, 
clinical professionals, and, health care consumers 
Standards: A principle commonly agreed upon by experts in the conduct and use of 
an evaluation for the measure of the value or quality of an evaluation (e.g., accuracy, 
feasibility, propriety, utility). 
Accuracy: The extent to which an evaluation is truthful or valid in what it says about 
a program, project, or material. 
Feasibility: Planned evaluation activities realistic given the time, resources, and 
expertise at hand. 
Propriety: The extent to which the evaluation has been conducted in a manner that 
evidences uncompromising adherence to the highest principles and ideals (including 
professional ethics, civil law, moral code, and contractual agreements).  
Utility: The extent to which an evaluation produces and disseminates reports that 
inform relevant audiences and have beneficial impact on their work.  
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STROKE DEFINITIONS 
McCance and Huether, 2009 
Ischemic Stroke: result when an artery to the brain is block, often by a blood clot or 
a fatty deposit due atherosclerosis.  
Thrombotic Stroke: arterial occlusions caused by thrombi formed in the arteries 
supplying the brain or intracranial vessels. 
Transient Ischemic attacks: thrombotic particles causing an intermittent blockage of 
circulation or spasm. 
Embolic Stroke: involves fragments that break from a thrombus formed outside the 
brain or in the heart, aorta, common carotid, or thorax. 
The Joint Commission, 2010 Core Performance Measure: one common set of 
measure specifications. The goal is to minimize data collection efforts for these common 
measures and focus efforts on the use of data to improve the health care delivery process. 
Center for Disease Control and Prevention, 2011 The International 
Classification of Diseases (ICD): is designed to promote international comparability in 
the collection, processing, classification, and presentation of mortality statistics. 
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APPENDIX B 
STK CORE MEASURES 
 
Stroke (STK) Core Measure Set 
 
STK-1 Venous Thromboembolism (VTE) Prophylaxis@ 
STK-2 Discharged on Antithrombotic Therapy@ 
STK-3 Anticoagulation Therapy for Atrial Fibrillation/Flutter@ 
STK-4 Thrombolytic Therapy@ 
STK-5 Antithrombotic Therapy By End of Hospital Day 2@ 
STK-6 Discharged on Statin Medication@ 
STK-8 Stroke Education@ 
STK-10 Assessed for Rehabilitation@ 
 
 
@ denotes Accountability evaluation pending 
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APPENDIX C 
ICD 9 CODES 
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APPENDIX D 
STROKE PROTOCOL 
(Attached pages) 
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APPENDIX E 
CDC FRAMEWORKS 
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APPENDIX F 
STROKE MAPS 
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APPENDIX G 
BRFSS DATA 
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APPENDIX H 
ORGANIZATIONAL CHART 
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APPENDIX I 
LETTER OF CONSENT 
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APPENDIX J 
IRB APPROVAL 
 
 
 
Biomedical IRB  
Notice of Excluded Activity 
 
 
DATE:  January 27, 2012 
 
TO:  Dr. Patricia Smyer, School of Nursing 
 
FROM: Office of Research Integrity – Human Subjects 
     
RE:  Notification of IRB Action 
 Protocol Title: Program Evaluation of Stroke Protocol in a Rural Nevada 
Hospital 
 Protocol# 1201-3997 
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-
________________________________________________________________________
__________ 
 
This memorandum is notification that the project referenced above has been reviewed 
as indicated in Federal regulatory statutes 45CFR46.   
 
The protocol has been reviewed and deemed excluded from IRB review.  It is not in 
need of further review or approval by the IRB. 
 
Any changes to the excluded activity may cause this project to require a different level 
of IRB review.  Should any changes need to be made, please submit a Modification 
Form. 
 
If you have questions or require any assistance, please contact the Office of Research 
Integrity – Human Subjects at IRB@unlv.edu or call 895-2794. 
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